Molecular Templates to Present at the 2017 Wedbush PacGrow Healthcare Conference

AUSTIN, Texas, Aug. 14, 2017 (GLOBE NEWSWIRE) — Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, today announced that Eric E. Poma, Ph.D., Chief Executive and Chief Scientific Officer, will provide a corporate overview at the 2017 Wedbush PacGrow Healthcare Conference, taking place August 15-16 at the Le Parker Meridien hotel in New York City.

Presentation Details:
Date:   Tuesday, August 15th
Time:   2:30pm Eastern Time
Location:   Le Parker Meridien Hotel, Mirus Room
Webcast:   http://wsw.com/webcast/wedbush33/mtem

About Molecular Templates  
Molecular Templates is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases.  For additional information, please visit Molecular Templates’ website at www.mtem.com.

CONTACT: Investor Contact:
Andrew McDonald, Ph.D.
andrew@lifesciadvisors.com
646-597-6987

Ads